Tibbs T, Donoghue L, Buzzelli A, Misumi I, DeMonia M, Ferris M
iScience. 2023; 26(11):108348.
PMID: 38026197
PMC: 10665959.
DOI: 10.1016/j.isci.2023.108348.
Tersteegen A, Sorg U, Virgen-Slane R, Helle M, Petzsch P, Dunay I
Infect Immun. 2021; 89(6).
PMID: 33753412
PMC: 8316152.
DOI: 10.1128/IAI.00026-21.
Xie M, Yunis J, Yao Y, Shi J, Yang Y, Zhou P
Clin Transl Immunology. 2021; 10(2):e1251.
PMID: 33614032
PMC: 7883478.
DOI: 10.1002/cti2.1251.
Grigoryan L, Pulendran B
Semin Immunol. 2020; 50:101422.
PMID: 33262067
PMC: 7670910.
DOI: 10.1016/j.smim.2020.101422.
Hickerson B, Sefing E, Bailey K, Van Wettere A, Penichet M, Gowen B
Elife. 2020; 9.
PMID: 32452770
PMC: 7297529.
DOI: 10.7554/eLife.55352.
Identification of a Locus in Mice that Regulates the Collateral Damage and Lethality of Virus Infection.
Misumi I, Cook K, Mitchell J, Lund M, Vick S, Lee R
Cell Rep. 2019; 27(5):1387-1396.e5.
PMID: 31042467
PMC: 6508094.
DOI: 10.1016/j.celrep.2019.04.004.
Effective Treatment of Experimental Lymphocytic Choriomeningitis Virus Infection: Consideration of Favipiravir for Use With Infected Organ Transplant Recipients.
Hickerson B, Westover J, Jung K, Komeno T, Furuta Y, Gowen B
J Infect Dis. 2018; 218(4):522-527.
PMID: 29762684
PMC: 6047442.
DOI: 10.1093/infdis/jiy159.
Lymphotoxin in physiology of lymphoid tissues - Implication for antiviral defense.
Koroleva E, Fu Y, Tumanov A
Cytokine. 2016; 101:39-47.
PMID: 27623349
PMC: 5344785.
DOI: 10.1016/j.cyto.2016.08.018.
Type I interferon is a therapeutic target for virus-induced lethal vascular damage.
Baccala R, Welch M, Gonzalez-Quintial R, Walsh K, Teijaro J, Nguyen A
Proc Natl Acad Sci U S A. 2014; 111(24):8925-30.
PMID: 24889626
PMC: 4066519.
DOI: 10.1073/pnas.1408148111.
Lymphocytic choriomeningitis virus infection in FVB mouse produces hemorrhagic disease.
Schnell F, Sundholm S, Crumley S, Iversen P, Mourich D
PLoS Pathog. 2013; 8(12):e1003073.
PMID: 23300439
PMC: 3531503.
DOI: 10.1371/journal.ppat.1003073.
Fine-tuning of dendritic cell biology by the TNF superfamily.
Summers deLuca L, Gommerman J
Nat Rev Immunol. 2012; 12(5):339-51.
PMID: 22487654
DOI: 10.1038/nri3193.
LTβR signaling in dendritic cells induces a type I IFN response that is required for optimal clonal expansion of CD8+ T cells.
Summers deLuca L, Ng D, Gao Y, Wortzman M, Watts T, Gommerman J
Proc Natl Acad Sci U S A. 2011; 108(5):2046-51.
PMID: 21245292
PMC: 3033245.
DOI: 10.1073/pnas.1014188108.
A lymphotoxin-driven pathway to hepatocellular carcinoma.
Haybaeck J, Zeller N, Wolf M, Weber A, Wagner U, Kurrer M
Cancer Cell. 2009; 16(4):295-308.
PMID: 19800575
PMC: 4422166.
DOI: 10.1016/j.ccr.2009.08.021.
Requirement of B cells for generating CD4+ T cell memory.
Whitmire J, Asano M, Kaech S, Sarkar S, Hannum L, Shlomchik M
J Immunol. 2009; 182(4):1868-76.
PMID: 19201839
PMC: 2658628.
DOI: 10.4049/jimmunol.0802501.
Genomic organization and phylogenetic utility of deer mouse (Peromyscus maniculatus) lymphotoxin-alpha and lymphotoxin-beta.
Richens T, Palmer A, Prescott J, Schountz T
BMC Immunol. 2008; 9:62.
PMID: 18976466
PMC: 2605436.
DOI: 10.1186/1471-2172-9-62.
Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways.
Ware C
Immunol Rev. 2008; 223:186-201.
PMID: 18613837
PMC: 2613484.
DOI: 10.1111/j.1600-065X.2008.00629.x.
LIGHT-related molecular network in the regulation of innate and adaptive immunity.
Xu Y, Tamada K, Chen L
Immunol Res. 2007; 37(1):17-32.
PMID: 17496344
DOI: 10.1007/BF02686093.
The lymphotoxin pathway: beyond lymph node development.
McCarthy D, Summers-Deluca L, Vu F, Chiu S, Gao Y, Gommerman J
Immunol Res. 2006; 35(1-2):41-54.
PMID: 17003508
DOI: 10.1385/IR:35:1:41.
Role of lymphotoxin in experimental models of infectious diseases: potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway.
Spahn T, Eugster H, Fontana A, Domschke W, Kucharzik T
Infect Immun. 2005; 73(11):7077-88.
PMID: 16239501
PMC: 1273913.
DOI: 10.1128/IAI.73.11.7077-7088.2005.
A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT.
Gommerman J, Giza K, Perper S, Sizing I, Ngam-ek A, Nickerson-Nutter C
J Clin Invest. 2003; 112(5):755-67.
PMID: 12952924
PMC: 182210.
DOI: 10.1172/JCI18648.